QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NASDAQ:CSII

Cardiovascular Systems (CSII) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$20.00
$20.00
50-Day Range
$19.87
$20.00
52-Week Range
$12.26
$20.57
Volume
4,300 shs
Average Volume
765,906 shs
Market Capitalization
$843.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00

Cardiovascular Systems MarketRank™ Forecast

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.05
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.68) to ($0.51) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.04 out of 5 stars

Medical Sector

948th out of 964 stocks

Surgical & Medical Instruments Industry

98th out of 98 stocks


CSII stock logo

About Cardiovascular Systems (NASDAQ:CSII) Stock

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.


CSII Stock News Headlines

U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Cardiovascular Technologist
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Abbott Completes Acquisition of Cardiovascular Systems, Inc.
CSII Cardiovascular Systems, Inc.
See More Headlines
Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

CSII Company Calendar

Last Earnings
2/08/2023
Today
9/26/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
780
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$20.00
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$15.00
Forecasted Upside/Downside
0.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$-36,930,000.00
Pretax Margin
-15.73%

Debt

Sales & Book Value

Annual Sales
$239.84 million
Book Value
$6.12 per share

Miscellaneous

Free Float
40,594,000
Market Cap
$843.96 million
Optionable
Optionable
Beta
0.74

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Scott R. WardScott R. Ward
    Chairman, President & Chief Executive Officer
  • John M. Hastings
    Executive Vice President-Operations & Technology
  • Jeffrey S. PointsJeffrey S. Points
    Chief Financial Officer
  • Jeffery W. Chambers
    Chief Medical Officer
  • Andrew P. O'Brien
    Vice President-Information Technology













CSII Stock - Frequently Asked Questions

Should I buy or sell Cardiovascular Systems stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" CSII shares.
View CSII analyst ratings
or view top-rated stocks.

What is Cardiovascular Systems' stock price forecast for 2023?

2 Wall Street analysts have issued 1-year price targets for Cardiovascular Systems' shares. Their CSII share price forecasts range from $15.00 to $25.00. On average, they anticipate the company's stock price to reach $20.00 in the next twelve months.
View analysts price targets for CSII
or view top-rated stocks among Wall Street analysts.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings data on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company had revenue of $61.45 million for the quarter, compared to analysts' expectations of $63.06 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 15.39% and a negative net margin of 15.79%. Cardiovascular Systems's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.23) earnings per share.

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Who are Cardiovascular Systems' major shareholders?

Cardiovascular Systems' stock is owned by many different retail and institutional investors. Top institutional investors include Walleye Trading LLC (0.00%), BROOKFIELD Corp ON (0.00%), Simplex Trading LLC (0.00%) and Picton Mahoney Asset Management (0.00%). Insiders that own company stock include Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb and Scott R Ward.
View institutional ownership trends
.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $20.00.

How much money does Cardiovascular Systems make?

Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $843.96 million and generates $239.84 million in revenue each year. The medical device company earns $-36,930,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis.

How many employees does Cardiovascular Systems have?

The company employs 780 workers across the globe.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for the company is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355.

This page (NASDAQ:CSII) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -